Bioinformatics study of the a222v substitution in sars-cov-2 spike protein

Kiky Martha Ariesaka  -  Department of Medicine, Faculty of Medicine, State University of Malang, Malang, Indonesia
Moh Mirza Nuryady*  -  Institute of Parasitology, Department of Biological Science and Pathobiology, Veterinary Medicine University of Vienna, Vienna, Austria
Ika Agus Rini  -  Department of Integrative Biotechnology, Sungkyunkwan University Gyeonggi-do, Suwon, Jangan-gu, Cheoncheon-dong, Seobu-ro 2066, Korea, Republic of

(*) Corresponding Author
DOI: 10.30659/sainsmed.v16i2.39242
COVID-19, caused by SARS-CoV-2, has infected over 200 million people and caused 4.3 million deaths globally, with over 3.7 million cases and 110,000 deaths in Indonesia. SARS-CoV-2, a single-stranded RNA virus, has a genome encoding proteins such as Spike (S), Envelope (E), Membrane (M), and Nucleocapsid (N). The S protein, comprising S1 and S2 domains, facilitates ACE2 receptor binding and membrane fusion. This study examines the phylogenetic relationship of the A222V substitution in the S protein with various global isolates. We collected 25 complete SARS-CoV-2 sequences from the GISAID database, performed multiple sequence alignments using Clustal W in MEGA-X software, and constructed phylogenetic trees using the neighbor-joining method. The urgency of this paper lies in understanding the impact of the A222V mutation on the virus's infectivity and spread, which is crucial for developing targeted treatments and vaccines. The A222V variant, first identified in Spain in summer 2020, has spread rapidly across Europe, raising concerns about its potential to increase transmissibility or affect vaccine efficacy. The A222V variant likely affects protein conformation or stability rather than receptor binding or membrane fusion. Understanding these changes is essential as it can influence the virus's behavior and efficacy of public health interventions. The study found high mutation rates in the S gene with diverse point mutations. Phylogenetic analysis revealed that A222V isolates clustered closely with D614G variants. In conclusion, not all mutations result in amino acid changes, and A222V has minimal impact on ACE2 binding but may influence protein stability.

Keywords: SARS-CoV-2; A222V substitution; Spike protein Phylogenetic analysis; COVID-19; Mutations

  1. Alouane, T., Laamarti, M., Essabbar, A., Hakmi, M., Bouricha, E. M., Chemao-Elfihri, M. W., Kartti, S., Boumajdi, N., Bendani, H., Laamarti, R., Ghrifi, F., Allam, L., Aanniz, T., Ouadghiri, M., El Hafidi, N., El Jaoudi, R., Benrahma, H., Attar, J. El, Mentag, R., Sbabou, L., Nejjari, C., Amzazi, S., Belyamani, L., Ibrahimi, A. (2020). Genomic diversity and hotspot mutations in 30,983 SARS-CoV-2 genomes: Moving toward a universal vaccine for the “Confined virus”? Pathogens, 9(829): 1-19. https://doi.org/10.3390/pathogens9100829
  2. COVID-19 Task Force. (2021). Situasi Virus COVID-19 di Indonesia.
  3. Gaffar, S., Rahmani, S. A. F., & Hardianto, A. (2021). Mutation and phylogenetic analysis of spike glycoprotein of indonesian isolates of severe-acute-respiratory-syndrome-coronavirus-2 (SARS-CoV-2). Majalah Kedokteran Bandung, 53(1): 38-47. https://doi.org/10.15395/mkb.v53n1.223
  4. Harvey, W. T., Carabelli, A. M., Jackson, B., Gupta, R. K., Thomson, E. C., Harrison, E. M., Ludden, C., Reeve, R., Rambaut, A., Peacock, S. J., & Robertson, D. L. (2021). SARS-CoV-2 variants, spike mutations and immune escape. Nature Reviews Microbiology, 19(7): 409–424. https://doi.org/10.1038/s41579-021-00573-0
  5. Hodcroft, E. B., Zuber, M., Nadeau, S., Vaughan, T. G., Crawford, K. H. D., Althaus, C. L., Reichmuth, M. L., Bowen, J. E., Walls, A. C., Corti, D., Bloom, J. D., Veesler, D., Mateo, D., Hernando, A., Comas, I., González Candelas, F., SeqCOVID-SPAIN consortium, Stadler, T., & Neher, R. A. (2021). Emergence and spread of a SARS-CoV-2 variant through Europe in the summer of 2020. MedRxiv: The Preprint Server for Health Sciences :1-18. https://doi.org/10.1101/2020.10.25.20219063
  6. Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., … Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395(10223): 497–506. https://doi.org/10.1016/S0140-6736(20)30183-5
  7. Huang, Y., Yang, C., Xu, X., Xu, W., & Liu, S. (2020). Structural and functional properties of SARS-CoV-2 spike protein: Potential antivirus drug development for COVID-19. Acta Pharmacologica Sinica, 41(9): 1141–1149. https://doi.org/10.1038/s41401-020-0485-4
  8. Kaushal, N., Gupta, Y., Goyal, M., Khaiboullina, S. F., Baranwal, M., & Verma, S. C. (2020). Mutational frequencies of SARS-CoV-2 genome during the beginning months of the outbreak in USA. Pathogens, 9(565): 1-16. https://doi.org/10.3390/pathogens9070565
  9. Kumar, S., Stecher, G., Li, M., Knyaz, C., & Tamura, K. (2018). MEGA X: Molecular evolutionary genetics analysis across computing platforms. Molecular Biology and Evolution, 35(6): 1547–1549. https://doi.org/10.1093/molbev/msy096
  10. McCallum, M., Walls, A. C., Bowen, J. E., Corti, D., & Veesler, D. (2020). Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation. Nature Structural & Molecular Biology, 27(10): 942–949. https://doi.org/10.1038/s41594-020-0483-8
  11. Nei M, & Kumar S. (2000). Molecular Evolution and Phylogenetics. Oxford University Press.
  12. Shahhosseini, N., Babuadze, G. (Giorgi), Wong, G., & Kobinger, G. P. (2021). Mutation signatures and in silico docking of novel SARS-CoV-2 variants of concern. Microorganisms, 9(926): 1-15. https://doi.org/10.3390/microorganisms9050926
  13. Tortorici, M. A., Beltramello, M., Lempp, F. A., Pinto, D., Dang, H. V., Rosen, L. E., McCallum, M., Bowen, J., Minola, A., Jaconi, S., Zatta, F., De Marco, A., Guarino, B., Bianchi, S., Lauron, E. J., Tucker, H., Zhou, J., Peter, A., Havenar-Daughton, C., … Veesler, D. (2020). Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms. Science, 370(6519): 950–957. https://doi.org/10.1126/science.abe3354
  14. Wang, M. Y., Zhao, R., Gao, L. J., Gao, X. F., Wang, D. P., & Cao, J. M. (2020). SARS-CoV-2: Structure, biology, and structure-based therapeutics development. Frontiers in Cellular and Infection Microbiology, 10(November):1–17. https://doi.org/10.3389/fcimb.2020.587269
  15. Wong, R. S. Y. (2020). The SARS-CoV-2 uutbreak: An epidemiological and clinical perspective. SN Comprehensive Clinical Medicine, 2(11):1983–1991. https://doi.org/10.1007/s42399-020-00546-z
  16. World Health Organization. (2020). Naming the coronavirus disease (COVID-19) and the virus that causes it. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it. Accessed on 2 May 2021
  17. World Health Organization. (2021). WHO Coronavirus (COVID-19) Dashboard. https://data.who.int/dashboards/covid19/cases. Accessed on 2 June 2021
  18. Zhang, B., Zhou, X., Qiu, Y., Song, Y., Feng, F., Feng, J., Song, Q., Jia, Q., & Wang, J. (2020). Clinical characteristics of 82 cases of death from COVID-19. PLoS ONE, 15(7 July): 1–13. https://doi.org/10.1371/journal.pone.0235458
  19. Zhang, H., Penninger, J. M., Li, Y., Zhong, N., & Slutsky, A. S. (2020). Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Medicine, 46(4): 586–590. https://doi.org/10.1007/s00134-020-05985-9
  20. Zhu, C., He, G., Yin, Q., Zeng, L., Ye, X., Shi, Y., & Xu, W. (2021). Molecular biology of the SARs‐CoV‐2 spike protein: A review of current knowledge. Journal of Medical Virology, 93:5729‐574. https://doi.org/10.1002/jmv.27132

Open Access Copyright (c) 2025 Sains Medika: Jurnal Kedokteran dan Kesehatan
License URL: https://creativecommons.org/licenses/by/4.0

Sains Medika: Jurnal Kedokteran dan Kesehatan
is published by Faculty of Medicine Universitas Islam Sultan Agung, Indonesia in association with FOKI (FORUM KEDOKTERAN ISLAM INDONESIA).

Contact: Jl. Raya Kaligawe Km.4, PO BOX 1054/SM Semarang 50112, Indonesia
Phone: +62 8122-9933-369
Website: https://fkunissula.ac.id
Email: sainsmedika@unissula.ac.id

ISSN: 2339-093X (Online) | 2085-1545 (Print)
DOI : 10.30659/sainsmed

This work is licensed under a Creative Commons Attribution 4.0 International License

Get a feed by atom here, RRS2 here and OAI Links here

apps